US Patent Issued to Cornell Research Foundation, Sloan-Kettering Institute for Cancer Research on Oct. 6 for "Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,384, issued on Oct. 6, was assigned to Cornell Research Foundation Inc. (Ithaca, N.Y.) and Sloan-Kettering Institute for Cancer Research (New York).

"Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis" was invented by Shahin Rafii (New York), Fan Zhang (Fort Lee, N.J.) and Marco Seandel (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to adenovirus E4ORF1 gene and to endothelial cells engineered to express the E4ORF1 gene. The present invention also relates to uses of the E4ORF1 gene, and cells expressing the E4ORF1 gene, and to compositions compris...